Susquehanna International Group
DICE

Susquehanna International Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Susquehanna International Group’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,056
Closed -$1.02M – 13424
2023
Q2 		$1.02M Sell
22,056
-508
-2% -$17.6K ﹤0.01% 6620
2023
Q1 		$646K Buy
22,564
+14,378
+176% +$426K ﹤0.01% 7935
2022
Q4 		$255K Sell
8,186
-136,374
-94% -$4.45M ﹤0.01% 9499
2022
Q3 		$2.93M Buy
144,560
+109,176
+309% +$1.99M ﹤0.01% 4150
2022
Q2 		$549K Buy
+35,384
New +$609K ﹤0.01% 8039

Susquehanna International Group's DICE Position: Q3 2023 in Review

Susquehanna International Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 22,056 shares — an estimated $1.02M sold.

Susquehanna International Group first reported a position in DICE in Q2 2022 and held it in 5 quarters. The position peaked at $2.93M in Q3 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Susquehanna International Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 22,056 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.02M.
  • Susquehanna International Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Susquehanna International Group's DICE Therapeutics, Inc. Common Stock position peaked at $2.93M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.